In addition, the loss-of-function studies with specific pharmacological inhibitors and lentivirus-based shRNAs further indicated that SALL1-mediaed tumor suppression and senescence induction is controlled by both MAPK and mTOR signaling pathways. Here, SALL1 is linked to neoplasm.